Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Biostatistics: Overview

Biostatistics: Overview

Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Drug Products: Biologics, Biosimilars and Interchangeables

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Scientists' Warning to Humanity: Unnecessary Bureaucracy Is a Global Impediment to Productivity, Advancement of Human and Planetary Wellbeing, Science and Sustainability.

Microbial biotechnology·2026

Same author

The Australian MotherSafe enhanced service for nausea and vomiting in pregnancy and hyperemesis gravidarum: a mixed methods study.

BMC pregnancy and childbirth·2026

Same author

Machine learning based screening of potential paper mill publications in cancer research: methodological and cross sectional study.

BMJ (Clinical research ed.)·2026

Same author

Put pressure on publishers to follow best practice - external regulation is the answer.

Nature·2025

Same author

Long-Term Follow-Up of Patients Receiving Cell and Gene Therapy Products.

Human gene therapy·2025

Same author

Reply to Neveu and Neveu: Inference in an information-restricted environment.

Proceedings of the National Academy of Sciences of the United States of America·2025

Search research articles

Related Experiment Video

Updated: Apr 11, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Biobank classification in an Australian setting.

Amanda Rush¹, Jeffrey H Christiansen², Jake P Farrell²

¹1Children's Cancer Research Unit, Kids Research Institute, NSW, Australia.

Biopreservation and Biobanking

|June 3, 2015

Summary

This summary is machine-generated.

The Watson and Barnes biobank classification system, based on biospecimen access policies, is applicable in Australia. Poly-user biobanks are more resource-intensive and utilize more quality control measures than mono-/oligo-user biobanks.

More Related Videos

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

Published on: September 2, 2025

Establishment of a Clinic-based Biorepository

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Related Experiment Videos

Last Updated: Apr 11, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

Published on: September 2, 2025

Establishment of a Clinic-based Biorepository

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Area of Science:

Biorepository Science
Cancer Research Infrastructure
Health Services Research

Background:

A 2011 schema classified biobanks (mono-, oligo-, poly-user) based on biospecimen access.
The applicability of this classification in Australia required validation.

Purpose of the Study:

To assess the relevance of the Watson and Barnes biobank classification schema in an Australian context.
To analyze the characteristics differentiating biobank types within New South Wales.

Main Methods:

Identified 23 cancer biobanks in New South Wales using public data and expert consultation.
Administered a comprehensive face-to-face survey to biobank representatives.
Analyzed survey data using Microsoft Excel and IBM SPSS Statistics.

Main Results:

The cohort comprised 5 mono-user, 7 oligo-user, and 11 poly-user biobanks.
Poly-user biobanks had more staff, websites, and utilized more quality control and best practices.
Mono-/oligo-user biobanks were more likely to seek external advice.

Conclusions:

The biobank classification schema based on access policy is relevant in Australia.
Poly-user biobanks demonstrate greater operational capacity and adherence to best practices.
This classification aids in understanding and potentially optimizing biobank operations.